Artificial intelligence for small-molecule chemical probe design: why drug-centric models may not transfer cleanly
Artículo
Acceso abierto
Artículo
DOAJ
Artificial intelligence (AI) is increasingly used to design and optimize small molecules. However, most current workflows remain centered on drug-candidate objectives, such as potency, ADMET, and drug-likeness, rather th...
LCC LCC:Therapeutics. PharmacologyIdioma eng
Acceso abiertoRuta libre sin proxy. Acceso recomendado cuando no hay suscripción activa.
Open Access